Document detail
ID

oai:arXiv.org:2412.09376

Topic
Computer Science - Machine Learnin...
Author
Vlontzou, Maria Eleftheria Athanasiou, Maria Dalakleidi, Kalliopi Skampardoni, Ioanna Davatzikos, Christos Nikita, Konstantina
Category

Computer Science

Year

2024

listing date

12/18/2024

Keywords
interpretability diagnosis alzheimer disease machine
Metrics

Abstract

An interpretable machine learning (ML) framework is introduced to enhance the diagnosis of Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) by ensuring robustness of the ML models' interpretations.

The dataset used comprises volumetric measurements from brain MRI and genetic data from healthy individuals and patients with MCI/AD, obtained through the Alzheimer's Disease Neuroimaging Initiative.

The existing class imbalance is addressed by an ensemble learning approach, while various attribution-based and counterfactual-based interpretability methods are leveraged towards producing diverse explanations related to the pathophysiology of MCI/AD.

A unification method combining SHAP with counterfactual explanations assesses the interpretability techniques' robustness.

The best performing model yielded 87.5% balanced accuracy and 90.8% F1-score.

The attribution-based interpretability methods highlighted significant volumetric and genetic features related to MCI/AD risk.

The unification method provided useful insights regarding those features' necessity and sufficiency, further showcasing their significance in MCI/AD diagnosis.

;Comment: This preprint has not been peer-reviewed yet but has been submitted to a journal

Vlontzou, Maria Eleftheria,Athanasiou, Maria,Dalakleidi, Kalliopi,Skampardoni, Ioanna,Davatzikos, Christos,Nikita, Konstantina, 2024, A comprehensive interpretable machine learning framework for Mild Cognitive Impairment and Alzheimer's disease diagnosis

Document

Open

Share

Source

Articles recommended by ES/IODE AI

MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
Protocol for the promoting resilience in stress management (PRISM) intervention: a multi-site randomized controlled trial for adolescents and young adults with advanced cancer
cancer quality of life anxiety depression hope coping skills communication intervention randomized ayas outcomes resilience care trial cancer prism-ac advanced